BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Juntavee A, Sripa B, Pugkhem A, Khuntikeo N, Wongkham S. Expression of sialyl Lewisa relates to poor prognosis in cholangiocarcinoma. World J Gastroenterol 2005; 11(2): 249-254 [PMID: 15633225 DOI: 10.3748/wjg.v11.i2.249]
URL: https://www.wjgnet.com/1007-9327/full/v11/i2/249.htm
Number Citing Articles
1
Krajang Talabnin, Chutima Talabnin, Mayumi Ishihara, Parastoo Azadi, Sopit Wongkham, Banchob Sripa. Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell LinesAsian Pacific Journal of Cancer Prevention 2016; 17(2): 691 doi: 10.7314/APJCP.2016.17.2.691
2
Atit Silsirivanit. Glycans: potential therapeutic targets for cholangiocarcinoma and their therapeutic and diagnostic implicationsExpert Opinion on Therapeutic Targets 2021; 25(1): 1 doi: 10.1080/14728222.2021.1861250
3
Krajang Talabnin, Chutima Talabnin, Juthamas Khiaowichit, Nuchanard Sutatum, Pundit Asavaritikrai, Sanong Suksaweang, Taweesak Tongtawee, Mayumi Ishihara, Parastoo Azadi, Banchob Sripa. High expression of tissue O-linked glycans is associated with a malignant phenotype of cholangiocarcinomaJournal of International Medical Research 2021; 49(2): 030006052097686 doi: 10.1177/0300060520976864
4
Waraporn Saentaweesuk, Atit Silsirivanit, Kulthida Vaeteewoottacharn, Kanlayanee Sawanyawisuth, Chawalit Pairojkul, Ubon Cha'on, Somsiri Indramanee, Somchai Pinlaor, Thidarut Boonmars, Norie Araki, Chaisiri Wongkham. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosisClinica Chimica Acta 2018; 477: 66 doi: 10.1016/j.cca.2017.12.005
5
Krajang Talabnin, Chutima Talabnin, Tadahiro Kumagai, Nuchanard Sutatum, Juthamas Khiaowichit, Chawaboon Dechsukhum, Mayumi Ishihara, Parastoo Azadi, Banchob Sripa. Ganglioside GM2: a potential biomarker for cholangiocarcinomaJournal of International Medical Research 2020; 48(7): 030006052090321 doi: 10.1177/0300060520903216
6
Christopher D. Briggs, Christopher P. Neal, Christopher D. Mann, William P. Steward, Margaret M. Manson, David P. Berry. Prognostic molecular markers in cholangiocarcinoma: A systematic reviewEuropean Journal of Cancer 2009; 45(1): 33 doi: 10.1016/j.ejca.2008.08.024
7
Anthony T. Ruys, Bas Groot Koerkamp, Jimme K. Wiggers, Heinz-Josef Klümpen, Fiebo J. ten Kate, Thomas M. van Gulik. Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysisAnnals of Surgical Oncology 2014; 21(2): 487 doi: 10.1245/s10434-013-3286-x
8
Marut Laohaviroj, Yaovalux Chamgramol, Chawalit Pairojkul, Jason Mulvenna, Banchob Sripa. Clinicopathological Significance of Osteopontin in Cholangiocarcinoma CasesAsian Pacific Journal of Cancer Prevention 2016; 17(1): 201 doi: 10.7314/APJCP.2016.17.1.201
9
Atit Silsirivanit. Advances in Clinical Chemistry 2019; 89: 189 doi: 10.1016/bs.acc.2018.12.005
10
Byong Ku Bae, Seong Woo Hong, Yeo Goo Chang, Koo Yong Hahn, In Wook Paik, Hyucksang Lee. Prognostic Value of Preoperative Serum Levels of CEA and CA19-9 in Patients with Colorectal CancerJournal of the Korean Society of Coloproctology 2007; 23(5): 338 doi: 10.3393/jksc.2007.23.5.338
11
Noé Velázquez-Márquez, Gerardo Santos-López, Lucio Jiménez-Aranda, Julio Reyes-Leyva, Verónica Vallejo-Ruiz. Sialyl Lewis x expression in cervical scrapes of premalignant lesionsJournal of Biosciences 2012; 37(S1): 999 doi: 10.1007/s12038-012-9261-z
12
Atit Silsirivanit, Chatchai Phoomak, Sopit Wongkham. Diagnosis and Management of Cholangiocarcinoma2021; : 527 doi: 10.1007/978-3-030-70936-5_25
13
Sukanya Luang, Karuntarat Teeravirote, Waraporn Saentaweesuk, Prasertsri Ma-In, Atit Silsirivanit. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic CholangiocarcinomaMedicina 2020; 56(11): 616 doi: 10.3390/medicina56110616
14
Kazuaki Nakamura, Kazuhiko Nakabayashi, Kyaw Htet Aung, Kazuko Aizawa, Naoko Hori, Junji Yamauchi, Kenichiro Hata, Akito Tanoue, Diego Calvisi. DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation StatusPLOS ONE 2015; 10(3): e0120545 doi: 10.1371/journal.pone.0120545
15
Soo Young Moon, Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jae Jun Park, Jung Won Jeon, Jun Uk Lim, Seung Jung Jun, Yoon Jong Seo, Chi Hoon Lee. Preoperative Carbohydrate Antigen 19-9 Levels Can Predict Stage and Survival Rate in Patients with Colorectal CancerIntestinal Research 2013; 11(3): 184 doi: 10.5217/ir.2013.11.3.184
16
Krajang Talabnin, Chutima Talabnin, Mayumi Ishihara, Parastoo Azadi. Increased expression of the high‑mannose M6N2 and NeuAc3H3N3M3N2F tri‑antennary N‑glycans in cholangiocarcinomaOncology Letters 2017;  doi: 10.3892/ol.2017.7384
17
Sasiprapa Wattanavises, Atit Silsirivanit, Kanlayanee Sawanyawisuth, Ubon Cha’on, Sakda Waraasawapati, Waraporn Saentaweesuk, Sukanya Luang, Chalongchai Chalermwat, Chaisiri Wongkham, Sopit Wongkham. Increase of MAL-II Binding Alpha2,3-Sialylated Glycan Is Associated with 5-FU Resistance and Short Survival of Cholangiocarcinoma PatientsMedicina 2019; 55(12): 761 doi: 10.3390/medicina55120761
18
Chanchai Boonla, Banchob Sripa, Peti Thuwajit, Ubon Cha-On, Anucha Puapairoj, Masanao Miwa, Sopit Wongkham. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinomaWorld Journal of Gastroenterology 2005; 11(32): 4939-4946 doi: 10.3748/wjg.v11.i32.4939
19
Dirk Walter, Eva Herrmann, Ria Winkelmann, Jörg G Albert, Juliane Liese, Andreas Schnitzbauer, Stefan Zeuzem, Martin‐Leo Hansmann, Jan Peveling‐Oberhag, Sylvia Hartmann. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct – a potential novel tool for differential diagnosis of indeterminate biliary strictureHistopathology 2016; 69(6): 962 doi: 10.1111/his.13041
20
Jie Jiang, Zai Luo, Ren-Chao Zhang, Yue-Ling Wang, Jun Zhang, Ming-Yu Duan, Zheng-Jun Qiu, Chen Huang. Insights into the history and tendency of glycosylation and digestive system tumor: A bibliometric-based visual analysisWorld Journal of Gastrointestinal Oncology 2024; 16(3): 1059-1075 doi: 10.4251/wjgo.v16.i3.1059